UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
10.08
-0.63 (-5.88%)
At close: Feb 21, 2025, 4:00 PM
10.27
+0.19 (1.86%)
After-hours: Feb 21, 2025, 5:54 PM EST
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $425.37 million as of February 21, 2025. Its market cap has decreased by -13.92% in one year.
Market Cap
425.37M
Enterprise Value
293.90M
1-Year Change
-13.92%
Ranking
Category
Stock Price
$10.08
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $167.38M to $425.37M, an increase of 154.14%. That is a compound annual growth rate of 12.69%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |